Chemoinformaics analysis of QUERCETIN-3-SULFATE
| Molecular Weight | 382.302 | nRot | 3 |
| Heavy Atom Molecular Weight | 372.222 | nRig | 20 |
| Exact Molecular Weight | 381.999 | nRing | 3 |
| Solubility: LogS | -3.01 | nHRing | 1 |
| Solubility: LogP | 0.412 | No. of Aliphatic Rings | 0 |
| Acid Count | 1 | No. of Aromatic Rings | 3 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 36 | No. of Aliphatic Hetero Cycles | 0 |
| No. of Heavy Atom | 26 | No. of Aromatic Carbocycles | 2 |
| nHetero | 11 | No. of Aromatic Hetero Cycles | 1 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 10 | No. of Saturated Hetero Cycles | 0 |
| No. of Carbon atom | 15 | No. of Saturated Rings | 0 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 16 |
| No. of Oxygen atom | 10 | No. of Arom Bond | 17 |
| nHA | 9 | APOL | 42.6379 |
| nHD | 5 | BPOL | 21.0281 |
| QED | 0.329 |
| Synth | 2.758 |
| Natural Product Likeliness | 1.612 |
| NR-PPAR-gamma | 0.613 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Accepted |
| Golden Triangle | Accepted |
| Pgp-inh | 0.006 |
| Pgp-sub | 0.002 |
| HIA | 0.518 |
| CACO-2 | -5.499 |
| MDCK | 0.0000101 |
| BBB | 0.003 |
| PPB | 0.959338 |
| VDSS | 0.375 |
| FU | 0.0275931 |
| CYP1A2-inh | 0.719 |
| CYP1A2-sub | 0.118 |
| CYP2c19-inh | 0.033 |
| CYP2c19-sub | 0.04 |
| CYP2c9-inh | 0.479 |
| CYP2c9-sub | 0.695 |
| CYP2d6-inh | 0.207 |
| CYP2d6-sub | 0.167 |
| CYP3a4-inh | 0.09 |
| CYP3a4-sub | 0.024 |
| CL | 3.912 |
| T12 | 0.855 |
| hERG | 0.045 |
| Ames | 0.26 |
| ROA | 0.058 |
| SkinSen | 0.349 |
| Carcinogencity | 0.175 |
| EI | 0.931 |
| Respiratory | 0.396 |
| NR-Aromatase | 0.183 |
| Antiviral | Yes |
| Prediction | 0.672928 |